VWF, which is produced by endothelial cells in response to endothelial damage and promotes platelet aggregation, has higher levels in patients with AF compared to those in sinus rhythm and correlates with the arrhythmic burden [70,71,72,73]. This evidence concerns the gene VWF and atrial fibrillation.